Funding for this research was provided by:
Wellcome Trust (WT099079MA, WT099079MA)
DH | National Institute for Health Research (Imperial Biomedical Research Centre, Imperial BRC)
Vetenskapsrådet (7480, 7480)
Alfred Österlund Foundation
Knut and Alice Wallenberg Foundation, the Alfred Österlund Foundation, Hansa Biopharma, the Swedish Government Funds for Clinical Research.
Received: 22 November 2020
Accepted: 23 March 2021
First Online: 22 April 2021
: L.K.K.T. is now an employee of ViiV Healthcare and holds shares in GlaxoSmithKline. The authors declare no competing interests.